Goldman Sachs Group Inc Ovid Therapeutics Inc. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 104,435 shares of OVID stock, worth $30,286. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104,435
Previous 104,435 -0.0%
Holding current value
$30,286
Previous $32,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$0.31 - $0.96 $29,043 - $89,940
-93,688 Reduced 47.29%
104,435 $32,000
Q4 2024

Feb 11, 2025
BUY
$0.93 - $1.36 $63,094 - $92,267
67,844 Added 52.08%
198,123 $184,000
Q3 2024

Nov 14, 2024
BUY
$0.75 - $1.3 $2,589 - $4,488
3,453 Added 2.72%
130,279 $153,000
Q2 2024

Aug 13, 2024
BUY
$0.7 - $3.34 $47,489 - $226,592
67,842 Added 115.02%
126,826 $97,000
Q1 2024

May 15, 2024
SELL
$2.72 - $4.04 $7,645 - $11,356
-2,811 Reduced 4.55%
58,984 $179,000
Q4 2023

Feb 13, 2024
BUY
$2.98 - $3.78 $15,016 - $19,047
5,039 Added 8.88%
61,795 $198,000
Q3 2023

May 14, 2024
SELL
$3.23 - $3.97 $16,275 - $20,004
-5,039 Reduced 8.15%
56,756 $217,000
Q3 2023

Nov 14, 2023
SELL
$3.23 - $3.97 $30,252 - $37,183
-9,366 Reduced 14.16%
56,756 $217,000
Q2 2023

May 14, 2024
BUY
$2.53 - $3.89 $139,018 - $213,747
54,948 Added 491.75%
66,122 $216,000
Q2 2023

Aug 14, 2023
BUY
$2.53 - $3.89 $139,018 - $213,747
54,948 Added 491.75%
66,122 $216,000
Q1 2023

May 14, 2024
SELL
$1.88 - $2.85 $7,484 - $11,345
-3,981 Reduced 26.27%
11,174 $28,000
Q1 2023

May 11, 2023
SELL
$1.88 - $2.85 $7,484 - $11,345
-3,981 Reduced 26.27%
11,174 $28,000
Q4 2022

May 14, 2024
SELL
$1.43 - $1.89 $29,914 - $39,536
-20,919 Reduced 57.99%
15,155 $28,000
Q4 2022

Feb 13, 2023
SELL
$1.43 - $1.89 $29,914 - $39,536
-20,919 Reduced 57.99%
15,155 $28,000
Q3 2022

May 14, 2024
SELL
$1.84 - $2.26 $13,849 - $17,011
-7,527 Reduced 17.26%
36,074 $67,000
Q3 2022

Nov 10, 2022
SELL
$1.84 - $2.26 $13,849 - $17,011
-7,527 Reduced 17.26%
36,074 $0
Q2 2022

May 14, 2024
SELL
$1.69 - $3.31 $30,747 - $60,222
-18,194 Reduced 29.44%
43,601 $94,000
Q2 2022

Aug 15, 2022
SELL
$1.69 - $3.31 $2,950 - $5,779
-1,746 Reduced 3.85%
43,601 $94,000
Q1 2022

May 16, 2022
SELL
$2.65 - $3.49 $10,711 - $14,106
-4,042 Reduced 8.18%
45,347 $143,000
Q4 2021

Feb 14, 2022
SELL
$3.13 - $3.73 $150,728 - $179,621
-48,156 Reduced 49.37%
49,389 $158,000
Q3 2021

Nov 10, 2021
BUY
$3.31 - $4.04 $322,873 - $394,081
97,545 New
97,545 $328,000

Others Institutions Holding OVID

# of Institutions
83
Shares Held
39.8M
Call Options Held
1.7K
Put Options Held
100
View Full List

About Ovid Therapeutics Inc.

OVID Quotes by TradingView
  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $20.4M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email